Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | +45.28% | +6.09% | +7.75% | +10.56% | +20.91% | +36.41% | +64.00% | +93.72% | +163.09% | +173.03% | +350.82% |
| FP HCARE-A | +19.02% | +3.94% | +6.53% | +10.34% | +9.25% | +22.67% | +25.93% | +38.40% | +40.61% | +93.83% | +103.04% |
| SCBRMGHC | +10.74% | +2.25% | +5.00% | +6.38% | +3.73% | +14.65% | +20.10% | +47.97% | +22.97% | +74.79% | +128.32% |
| BCARE | +15.51% | +1.80% | +5.35% | +6.78% | +7.18% | +17.90% | +24.01% | +36.89% | +8.97% | +58.19% | +92.10% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes AMGN: money market or bond funds, or no holdings data yet
| FP HCARE-A | SCBRMGHC | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 8.91% | 9.70% |
 Johnson & Johnson | 7.53% | 7.85% |
 ABBVIE | 5.39% | 4.98% |
 AstraZeneca | 4.94% | 3.74% |
 Thermo Fisher | 3.16% | 3.38% |
 Roche | 3.51% | 2.70% |
| Only in FP HCARE-A | ||
 Amgen | 5.67% | N/A |
 Medtronic | 3.94% | N/A |
 McKesson | 3.10% | N/A |
 GSK | 2.99% | N/A |
| Only in SCBRMGHC | ||
 Unitedhealth Group | N/A | 4.31% |
 Novartis | N/A | 2.76% |
 argenx | N/A | 2.47% |
 Merck & | N/A | 2.37% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| AMGN | +45.28% | 29.68% | 1.53 |
| FP HCARE-A | +19.02% | 16.60% | 1.15 |
| BCARE | +15.51% | 15.99% | 0.97 |
| SCBRMGHC | +10.74% | 16.87% | 0.64 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | AMGN | FP HCARE-A | SCBRMGHC | BCARE |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 28.56 million | 2,422 million | 4,742 million |
| Inception date | N/A | 18 Aug 2014 | 6 Nov 2015 | 29 Aug 2007 |
| Master fund | N/A | Manulife Global Fund – Healthcare Fund | Janus Henderson Global Life Sciences Fund | Wellington Global Health Care Equity Fund |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Almost fully hedged | Hedged at the manager's discretion |
| Share hedged | N/A | 14.65% | 100.58% | 47.41% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1,000 THB | 1,000 THB | 500 THB |
| Subsequent purchase | N/A | No minimum | 1,000 THB | 500 THB |
| Redemption (amount) | N/A | No minimum | 1,000 THB | No minimum |
| Redemption (units) | N/A | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | 1,000 THB | No minimum |
| Balance (units) | N/A | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+5 | T+5 | T+4 |
